Abbott Richard David 4
4 · Co-Diagnostics, Inc. · Filed May 27, 2025
Insider Transaction Report
Form 4
Abbott Richard David
President
Transactions
- Disposition to Issuer
Common Stock
2025-05-23$0.24/sh−7,180$1,723→ 26,735 total - Award
Common Stock
2025-05-23+20,000→ 33,915 total - Exercise/Conversion
Restricted Stock Unit
2025-05-23−20,000→ 130,438 totalExercise: $0.00→ Common Stock (150,438 underlying)
Footnotes (2)
- [F1]Included in 120,000 restricted stock units awarded to the Reporting Person on April 26, 2024, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in 6 equal installments every 6 months commencing on November 23, 2024.
- [F2]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSU's. This sale is mandated by the Issuer's election, under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.